by Sauwakon Ratanawijitrasin, Eshetu Wondemagegnehu.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
[Geneva] :
Name of Publisher, Distributor, etc.
World Health Organization,
Date of Publication, Distribution, etc.
2002.
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource (ix, 139 pages) :
Other Physical Details
illustrations
GENERAL NOTES
Text of Note
"This report is a synthesis of the results of the multicountry studies carried out by the WHO Essential Drugs and Medicines Policy Unit (EDM)"--Page ix.
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references (pages 138-139).
CONTENTS NOTE
Text of Note
1. DRUG REGULATION: OBJECTIVES AND ISSUES; 2. MULTICOUNTRY STUDY ON EFFECTIVE DRUG REGULATION; 3. PROFILE OF THE COUNTRIES; 4. REGULATORY FRAMEWORK; 5. REGULATORY CAPACITY; 6. LICENSING OF MANUFACTURING, DISTRIBUTION AND RETAIL SALE; 7. INSPECTION AND SURVEILLANCE; 8. PRODUCT ASSESSMENT AND REGISTRATION; 9. CONTROL OF DRUG PROMOTION AND ADVERTISING; 10. DRUG QUALITY CONTROL LABORATORY; 11. ASSESSING REGULATORY PERFORMANCE; 12. CONCLUSIONS AND RECOMMENDATIONS FOR EFFECTIVE DRUG REGULATION.
0
SUMMARY OR ABSTRACT
Text of Note
Drugs play a crucial role in saving lives, restoring health, and preventing diseases and epidemics. But they need to be safe, efficacious, of good quality, and used rationally. This means that their production, import/export, storage, supply and distribution should be subject to government control through prescribed norms and standards and an effective regulatory system. Substandard and counterfeit drugs proliferate primarily in an environment where drug regulation has proved ineffective. This publication presents a synthesis of studies on drug regulation carried out in 10 countries: Australia.
SYSTEM REQUIREMENTS NOTE (ELECTRONIC RESOURCES)
Text of Note
Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
OTHER EDITION IN ANOTHER MEDIUM
Title
Effective drug regulation.
International Standard Book Number
9241562064
TOPICAL NAME USED AS SUBJECT
Drugs-- Law and legislation.
Pharmaceutical policy.
Cross-Cultural Comparison.
Drug and Narcotic Control.
Médicaments-- Droit.
Médicaments-- Politique gouvernementale.
Arzneimittelprüfung
Arzneimittelsicherheit
DROGAS-- ASPECTOS JURIDICOS.
DRUG CONTROL.
DRUG POLICY.
DRUG REQUIREMENTS.
Drugs-- Law and legislation.
Drugsgebruik.
Drugshandel.
HEALTH ECONOMICS.
Internationaler Vergleich
MEDICAL-- Allied Health Services-- General.
Pharmaceutical policy.
Regulering.
(SUBJECT CATEGORY (Provisional
MED-- 003000
DEWEY DECIMAL CLASSIFICATION
Number
362
.
1782
Edition
22
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RA401
.
A1
Book number
R38
2002eb
OTHER CLASS NUMBERS
Class number
86
.
42
Class number
QR
525
Class number
2002
K-267
Class number
QV
33
.
1
Book Number
R232e
2002
System Code
bcl
System Code
rvk
PERSONAL NAME - PRIMARY RESPONSIBILITY
Ratanawijitrasin, Sauwakon.
PERSONAL NAME - ALTERNATIVE RESPONSIBILITY
Wondemagegnehu, Eshetu.
CORPORATE BODY NAME - ALTERNATIVE RESPONSIBILITY
World Health Organization., Essential Drugs and Medicines Policy.